TreeWAS – Variant ID: rs4795067

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
Z02.8 Other examinations for administrative purposes	0.547	0.453	0.000
Z02 Examination and encounter for administrative purposes	0.229	0.771	0.000
Z02.9 Examination for administrative purposes, unspecified	0.164	0.836	0.000
Z02.7 Issue of medical certificate	0.164	0.836	0.000
Z02.6 Examination for insurance purposes	0.164	0.836	0.000
Z02.5 Examination for participation in sport	0.164	0.836	0.000
Z02.4 Examination for driving licence	0.164	0.836	0.000
Z02.3 Examination for recruitment to armed forces	0.164	0.836	0.000
Z02.2 Examination for admission to residential institution	0.164	0.836	0.000
Z02.1 Pre-employment examination	0.164	0.836	0.000
Z02.0 Examination for admission to educational institution	0.164	0.836	0.000
L40.9 Psoriasis, unspecified	0.107	0.893	0.000
L40 Psoriasis	0.078	0.922	0.000
L40.1 Generalised pustular psoriasis	0.065	0.935	0.000
L40.5 Arthropathic psoriasis	0.060	0.940	0.000
L40.8 Other psoriasis	0.059	0.941	0.000
L40.2 Acrodermatitis continua	0.056	0.944	0.000
L40.3 Pustulosis palmaris et plantaris	0.055	0.945	0.000
L40.4 Guttate psoriasis	0.054	0.946	0.000
L40.0 Psoriasis vulgaris	0.048	0.952	0.000
L40-L45 Papulosquamous disorders	0.045	0.955	0.000
L43 Lichen planus	0.035	0.965	0.000
L44 Other papulosquamous disorders	0.032	0.968	0.000
L41 Parapsoriasis	0.032	0.968	0.000
L45 Papulosquamous disorders in diseases classified elsewhere	0.032	0.968	0.000
L42 Pityriasis rosea	0.031	0.969	0.000
L43.9 Lichen planus, unspecified	0.029	0.971	0.000
H72.8 Other perforations of tympanic membrane	0.000	0.972	0.028
H72 Perforation of tympanic membrane	0.000	0.973	0.027
L43.3 Subacute (active) lichen planus	0.025	0.975	0.000
L43.2 Lichenoid drug reaction	0.025	0.975	0.000
L43.1 Bullous lichen planus	0.025	0.975	0.000
L43.0 Hypertrophic lichen planus	0.025	0.975	0.000
L43.8 Other lichen planus	0.024	0.976	0.000
L41.9 Parapsoriasis, unspecified	0.023	0.976	0.000
L41.8 Other parapsoriasis	0.023	0.976	0.000
L41.5 Retiform parapsoriasis	0.023	0.976	0.000
L41.4 Large plaque parapsoriasis	0.023	0.976	0.000
L41.3 Small plaque parapsoriasis	0.023	0.976	0.000
L41.2 Lymphomatoid papulosis	0.023	0.976	0.000
L41.1 Pityriasis lichenoides chronica	0.023	0.976	0.000
L41.0 Pityriasis lichenoides et varioliformis acuta	0.023	0.976	0.000
L44.9 Papulosquamous disorder, unspecified	0.023	0.976	0.000
L44.8 Other specified papulosquamous disorders	0.023	0.976	0.000
L44.4 Infantile papular acrodermatitis [Giannotti-Crosti]	0.023	0.976	0.000
L44.3 Lichen ruber moniliformis	0.023	0.976	0.000
L44.2 Lichen striatus	0.023	0.976	0.000
L44.1 Lichen nitidus	0.023	0.976	0.000
L44.0 Pityriasis rubra pilaris	0.023	0.976	0.000
H65-H75 Diseases of middle ear and mastoid	0.000	0.977	0.023
H72.1 Attic perforation of tympanic membrane	0.000	0.977	0.023
H66 Suppurative and unspecified otitis media	0.000	0.977	0.023
H71 Cholesteatoma of middle ear	0.000	0.977	0.023
H72.9 Perforation of tympanic membrane, unspecified	0.000	0.977	0.023
H72.2 Other marginal perforations of tympanic membrane	0.000	0.978	0.022
H66.9 Otitis media, unspecified	0.000	0.980	0.020
H66.2 Chronic atticoantral suppurative otitis media	0.000	0.980	0.020
H66.4 Suppurative otitis media, unspecified	0.000	0.980	0.020
L30.9 Dermatitis, unspecified	0.020	0.980	0.000
H72.0 Central perforation of tympanic membrane	0.000	0.981	0.019
H66.1 Chronic tubotympanic suppurative otitis media	0.000	0.981	0.019
H70 Mastoiditis and related conditions	0.000	0.982	0.018
L21.9 Seborrhoeic dermatitis, unspecified	0.018	0.982	0.000
H75 Other disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.983	0.017
H68 Eustachian salpingitis and obstruction	0.000	0.983	0.017
H67 Otitis media in diseases classified elsewhere	0.000	0.983	0.017
H66.3 Other chronic suppurative otitis media	0.000	0.983	0.017
L21 Seborrhoeic dermatitis	0.017	0.983	0.000
Chapter XII Diseases of the skin and subcutaneous tissue	0.017	0.983	0.000
L30 Other dermatitis	0.017	0.983	0.000
L20-L30 Dermatitis and eczema	0.016	0.984	0.000
H69 Other disorders of Eustachian tube	0.000	0.984	0.016
L50-L54 Urticaria and erythema	0.016	0.984	0.000
H74 Other disorders of middle ear and mastoid	0.000	0.985	0.015
L55-L59 Radiation-related disorders of the skin and subcutaneous tissue	0.015	0.985	0.000
C85.1 B-cell lymphoma, unspecified	0.000	0.985	0.015
N60.1 Diffuse cystic mastopathy	0.000	0.985	0.015
H66.0 Acute suppurative otitis media	0.000	0.985	0.015
L50 Urticaria	0.014	0.986	0.000
L51 Erythema multiforme	0.014	0.986	0.000
H70.8 Other mastoiditis and related conditions	0.000	0.986	0.014
H73 Other disorders of tympanic membrane	0.000	0.986	0.014
L26 Exfoliative dermatitis	0.013	0.986	0.000
H70.9 Mastoiditis, unspecified	0.000	0.987	0.013
H74.3 Other acquired abnormalities of ear ossicles	0.000	0.987	0.013
H70.1 Chronic mastoiditis	0.000	0.987	0.013
H70.2 Petrositis	0.000	0.987	0.013
H70.0 Acute mastoiditis	0.000	0.987	0.013
L51.1 Bullous erythema multiforme	0.013	0.987	0.000
L30.4 Erythema intertrigo	0.013	0.987	0.000
L57 Skin changes due to chronic exposure to nonionising radiation	0.013	0.987	0.000
T40.2 Other opioids	0.000	0.987	0.013
H65 Nonsuppurative otitis media	0.000	0.987	0.013
H69.9 Eustachian tube disorder, unspecified	0.000	0.987	0.013
L53 Other erythematous conditions	0.013	0.987	0.000
H65.4 Other chronic nonsuppurative otitis media	0.000	0.987	0.013
L56 Other acute skin changes due to ultraviolet radiation	0.013	0.987	0.000
H67.8 Otitis media in other diseases classified elsewhere	0.000	0.987	0.012
H67.1 Otitis media in viral diseases classified elsewhere	0.000	0.987	0.012
H67.0 Otitis media in bacterial diseases classified elsewhere	0.000	0.987	0.012
H68.1 Obstruction of Eustachian tube	0.000	0.987	0.012
H68.0 Eustachian salpingitis	0.000	0.987	0.012
H75.8 Other specified disorders of middle ear and mastoid in diseases classified elsewhere	0.000	0.987	0.012
H75.0 Mastoiditis in infectious and parasitic diseases classified elsewhere	0.000	0.987	0.012
L57.8 Other skin changes due to chronic exposure to nonionising radiation	0.012	0.988	0.000
L21.8 Other seborrhoeic dermatitis	0.012	0.988	0.000
L21.1 Seborrhoeic infantile dermatitis	0.012	0.988	0.000
L21.0 Seborrhoea capitis	0.012	0.988	0.000
L30.5 Pityriasis alba	0.012	0.988	0.000
L30.2 Cutaneous autosensitisation	0.012	0.988	0.000
L30.0 Nummular dermatitis	0.012	0.988	0.000
L50.0 Allergic urticaria	0.012	0.988	0.000
L30.3 Infective dermatitis	0.012	0.988	0.000
L10-L14 Bullous disorders	0.012	0.988	0.000
L24 Irritant contact dermatitis	0.012	0.988	0.000
L22 Diaper [napkin] dermatitis	0.012	0.988	0.000
L50.1 Idiopathic urticaria	0.012	0.988	0.000
L53.9 Erythematous condition, unspecified	0.012	0.988	0.000
H69.0 Patulous Eustachian tube	0.000	0.988	0.011
L30.1 Dyshidrosis [pompholyx]	0.011	0.988	0.000
L54 Erythema in diseases classified elsewhere	0.011	0.988	0.000
H74.8 Other specified disorders of middle ear and mastoid	0.000	0.988	0.011
L59 Other disorders of skin and subcutaneous tissue related to radiation	0.011	0.989	0.000
L50.9 Urticaria, unspecified	0.011	0.989	0.000
L58 Radiodermatitis	0.011	0.989	0.000
L55 Sunburn	0.011	0.989	0.000
T43.0 Tricyclic and tetracyclic antidepressants	0.000	0.989	0.011
L20 Atopic dermatitis	0.011	0.989	0.000
C43.3 Malignant melanoma of other and unspecified parts of face	0.000	0.989	0.011
L50.8 Other urticaria	0.011	0.989	0.000
H74.4 Polyp of middle ear	0.000	0.989	0.011
H74.2 Discontinuity and dislocation of ear ossicles	0.000	0.989	0.011
L23 Allergic contact dermatitis	0.011	0.989	0.000
T46 Poisoning by agents primarily affecting the cardiovascular system	0.000	0.989	0.011
T46.4 Angiotensin-converting-enzyme inhibitors	0.000	0.989	0.011
H65.0 Acute serous otitis media	0.000	0.989	0.011
L56.8 Other specified acute skin changes due to ultraviolet radiation	0.011	0.989	0.000
L50.6 Contact urticaria	0.010	0.989	0.000
L50.5 Cholinergic urticaria	0.010	0.989	0.000
L50.4 Vibratory urticaria	0.010	0.989	0.000
L50.3 Dermatographic urticaria	0.010	0.989	0.000
L50.2 Urticaria due to cold and heat	0.010	0.989	0.000
L57.9 Skin changes due to chronic exposure to nonionising radiation, unspecified	0.010	0.989	0.000
T40 Poisoning by narcotics and psychodysleptics [hallucinogens]	0.000	0.989	0.010
L51.8 Other erythema multiforme	0.010	0.990	0.000
L51.2 Toxic epidermal necrolysis [Lyell]	0.010	0.990	0.000
L51.0 Nonbullous erythema multiforme	0.010	0.990	0.000
T50.9 Other and unspecified drugs, medicaments and biological substances	0.000	0.990	0.010
H73.0 Acute myringitis	0.000	0.990	0.010
L25 Unspecified contact dermatitis	0.010	0.990	0.000
H74.0 Tympanosclerosis	0.000	0.990	0.010
H73.9 Disorder of tympanic membrane, unspecified	0.000	0.990	0.010
L57.5 Actinic granuloma	0.010	0.990	0.000
L11 Other acantholytic disorders	0.010	0.990	0.000
T36-T50 Poisoning by drugs, medicaments and biological substances	0.000	0.990	0.010
T50 Poisoning by diuretics and other and unspecified drugs, medicaments and biological substances	0.000	0.990	0.010
L57.4 Cutis laxa senilis	0.010	0.990	0.000
L56.9 Acute skin change due to ultraviolet radiation, unspecified	0.010	0.990	0.000
L57.3 Poikiloderma of Civatte	0.009	0.990	0.000
L57.2 Cutis rhomboidalis nuchae	0.009	0.990	0.000
L57.1 Actinic reticuloid	0.009	0.990	0.000
L53.3 Other chronic figurate erythema	0.009	0.990	0.000
L53.2 Erythema marginatum	0.009	0.990	0.000
L53.1 Erythema annulare centrifugum	0.009	0.990	0.000
T43 Poisoning by psychotropic drugs, not elsewhere classified	0.000	0.991	0.009
H73.1 Chronic myringitis	0.000	0.991	0.009
T78.4 Allergy, unspecified	0.009	0.991	0.000
L29 Pruritus	0.009	0.991	0.000
L56.4 Polymorphous light eruption	0.009	0.991	0.000
L56.3 Solar urticaria	0.009	0.991	0.000
L56.2 Photocontact dermatitis [berloque dermatitis]	0.009	0.991	0.000
L56.1 Drug photoallergic response	0.009	0.991	0.000
L56.0 Drug phototoxic response	0.009	0.991	0.000
H74.1 Adhesive middle ear disease	0.000	0.991	0.009
C85 Other and unspecified types of non-Hodgkin's lymphoma	0.000	0.991	0.009
T46.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.991	0.009
L53.0 Toxic erythema	0.009	0.991	0.000
T46.3 Coronary vasodilators, not elsewhere classified	0.000	0.991	0.009
L10 Pemphigus	0.009	0.991	0.000
L51.9 Erythema multiforme, unspecified	0.009	0.991	0.000
C85.7 Other specified types of non-Hodgkin's lymphoma	0.000	0.991	0.009
H65.2 Chronic serous otitis media	0.000	0.991	0.009
L59.8 Other specified disorders of skin and subcutaneous tissue related to radiation	0.009	0.991	0.000
L14 Bullous disorders in diseases classified elsewhere	0.009	0.991	0.000
L24.9 Irritant contact dermatitis, unspecified cause	0.009	0.991	0.000
L24.8 Irritant contact dermatitis due to other agents	0.009	0.991	0.000
L24.7 Irritant contact dermatitis due to plants, except food	0.009	0.991	0.000
L24.6 Irritant contact dermatitis due to food in contact with the skin	0.009	0.991	0.000
L24.5 Irritant contact dermatitis due to other chemical products	0.009	0.991	0.000
L24.4 Irritant contact dermatitis due to drugs in contact with the skin	0.009	0.991	0.000
L24.3 Irritant contact dermatitis due to cosmetics	0.009	0.991	0.000
L24.2 Irritant contact dermatitis due to solvents	0.009	0.991	0.000
L24.1 Irritant contact dermatitis due to oils and greases	0.009	0.991	0.000
L24.0 Irritant contact dermatitis due to detergents	0.009	0.991	0.000
T42 Poisoning by antiepileptic, sedative-hypnotic and anti-Parkinsonism drugs	0.000	0.991	0.009
T43.5 Other and unspecified antipsychotics and neuroleptics	0.000	0.991	0.009
H74.9 Disorder of middle ear and mastoid, unspecified	0.000	0.991	0.008
L23.1 Allergic contact dermatitis due to adhesives	0.008	0.991	0.000
L54.8 Erythema in other diseases classified elsewhere	0.008	0.991	0.000
L54.0 Erythema marginatum in acute rheumatic fever	0.008	0.991	0.000
L52 Erythema nodosum	0.008	0.991	0.000
L11.0 Acquired keratosis follicularis	0.008	0.991	0.000
L59.9 Disorder of skin and subcutaneous tissue related to radiation, unspecified	0.008	0.992	0.000
L59.0 Erythema ab igne [dermatitis ab igne]	0.008	0.992	0.000
L29.0 Pruritus ani	0.008	0.992	0.000
T46.6 Antihyperlipidaemic and antiarteriosclerotic drugs	0.000	0.992	0.008
L53.8 Other specified erythematous conditions	0.008	0.992	0.000
L55.9 Sunburn, unspecified	0.008	0.992	0.000
L55.8 Other sunburn	0.008	0.992	0.000
L55.2 Sunburn of third degree	0.008	0.992	0.000
L55.1 Sunburn of second degree	0.008	0.992	0.000
L55.0 Sunburn of first degree	0.008	0.992	0.000
L58.9 Radiodermatitis, unspecified	0.008	0.992	0.000
L58.1 Chronic radiodermatitis	0.008	0.992	0.000
L58.0 Acute radiodermatitis	0.008	0.992	0.000
L20.0 Besnier's prurigo	0.008	0.992	0.000
T42.1 Iminostilbenes	0.000	0.992	0.008
L20.8 Other atopic dermatitis	0.008	0.992	0.000
L28 Lichen simplex chronicus and prurigo	0.008	0.992	0.000
T40.5 Cocaine	0.000	0.992	0.008
T50.4 Drugs affecting uric acid metabolism	0.000	0.992	0.008
L23.8 Allergic contact dermatitis due to other agents	0.008	0.992	0.000
L23.7 Allergic contact dermatitis due to plants, except food	0.008	0.992	0.000
L23.6 Allergic contact dermatitis due to food in contact with the skin	0.008	0.992	0.000
L23.4 Allergic contact dermatitis due to dyes	0.008	0.992	0.000
L23.3 Allergic contact dermatitis due to drugs in contact with the skin	0.008	0.992	0.000
L23.2 Allergic contact dermatitis due to cosmetics	0.008	0.992	0.000
L23.0 Allergic contact dermatitis due to metals	0.008	0.992	0.000
H65.1 Other acute nonsuppurative otitis media	0.000	0.992	0.008
T46.9 Other and unspecified agents primarily affecting the cardiovascular system	0.000	0.992	0.008
T46.8 Antivaricose drugs, including sclerosing agents	0.000	0.992	0.008
T46.7 Peripheral vasodilators	0.000	0.992	0.008
T46.2 Other antidysrhythmic drugs, not elsewhere classified	0.000	0.992	0.008
T46.0 Cardiac-stimulant glycosides and drugs of similar action	0.000	0.992	0.008
I74.3 Embolism and thrombosis of arteries of the lower extremities	0.008	0.992	0.000
H69.8 Other specified disorders of Eustachian tube	0.000	0.992	0.008
L23.9 Allergic contact dermatitis, unspecified cause	0.008	0.992	0.000
L12 Pemphigoid	0.008	0.992	0.000
T40.9 Other and unspecified psychodysleptics [hallucinogens]	0.000	0.992	0.008
T40.8 Lysergide [LSD]	0.000	0.992	0.008
T40.7 Cannabis (derivatives)	0.000	0.992	0.008
T40.3 Methadone	0.000	0.992	0.008
T40.0 Opium	0.000	0.992	0.008
T42.7 Antiepileptic and sedative-hypnotic drugs, unspecified	0.000	0.992	0.008
H73.8 Other specified disorders of tympanic membrane	0.000	0.992	0.008
L13 Other bullous disorders	0.007	0.992	0.000
T46.1 Calcium-channel blockers	0.000	0.992	0.008
L25.8 Unspecified contact dermatitis due to other agents	0.007	0.992	0.000
L25.5 Unspecified contact dermatitis due to plants, except food	0.007	0.992	0.000
L25.4 Unspecified contact dermatitis due to food in contact with the skin	0.007	0.992	0.000
L25.3 Unspecified contact dermatitis due to other chemical products	0.007	0.992	0.000
L25.2 Unspecified contact dermatitis due to dyes	0.007	0.992	0.000
L25.1 Unspecified contact dermatitis due to drugs in contact with the skin	0.007	0.992	0.000
L25.0 Unspecified contact dermatitis due to cosmetics	0.007	0.992	0.000
L29.3 Anogenital pruritus, unspecified	0.007	0.993	0.000
L20.9 Atopic dermatitis, unspecified	0.007	0.993	0.000
T49 Poisoning by topical agents primarily affecting skin and mucous membrane and by ophthalmological, otorhinolarygological and dental drugs	0.000	0.993	0.007
T48 Poisoning by agents primarily acting on smooth and skeletal muscles and the respiratory system	0.000	0.993	0.007
T41 Poisoning by anaesthetics and therapeutic gases	0.000	0.993	0.007
L11.9 Acantholytic disorder, unspecified	0.007	0.993	0.000
L11.8 Other specified acantholytic disorders	0.007	0.993	0.000
L11.1 Transient acantholytic dermatosis [Grover]	0.007	0.993	0.000
T50.7 Analeptics and opioid receptor antagonists	0.000	0.993	0.007
T50.5 Appetite depressants	0.000	0.993	0.007
T50.3 Electrolytic, caloric and water-balance agents	0.000	0.993	0.007
T50.1 Loop [high-ceiling] diuretics	0.000	0.993	0.007
T50.0 Mineralocorticoids and their antagonists	0.000	0.993	0.007
T43.1 Monoamine-oxidase-inhibitor antidepressants	0.000	0.993	0.007
T42.6 Other antiepileptic and sedative-hypnotic drugs	0.000	0.993	0.007
T50.6 Antidotes and chelating agents, not elsewhere classified	0.000	0.993	0.007
T40.1 Heroin	0.000	0.993	0.007
T50.2 Carbonic-anhydrase inhibitors, benzothiadiazides and other diuretics	0.000	0.993	0.007
T36 Poisoning by systemic antibiotics	0.000	0.993	0.007
T40.6 Other and unspecified narcotics	0.000	0.993	0.007
Z03.3 Observation for suspected nervous system disorder	0.007	0.993	0.000
T43.9 Psychotropic drug, unspecified	0.000	0.993	0.007
T43.8 Other psychotropic drugs, not elsewhere classified	0.000	0.993	0.007
L29.1 Pruritus scroti	0.007	0.993	0.000
M47.97 Spondylosis, unspecified (Lumbosacral region)	0.007	0.993	0.000
C85.2 Mediastinal (thymic) large B-cell lymphoma	0.000	0.993	0.007
T47 Poisoning by agents primarily affecting gastro-intestinal system	0.000	0.993	0.007
L10.9 Pemphigus, unspecified	0.007	0.993	0.000
T43.3 Phenothiazine antipsychotics and neuroleptics	0.000	0.993	0.007
D13.1 Stomach	0.000	0.993	0.007
C85.0 Lymphosarcoma	0.000	0.993	0.007
L10.8 Other pemphigus	0.006	0.993	0.000
L10.5 Drug-induced pemphigus	0.006	0.993	0.000
L10.4 Pemphigus erythematosus	0.006	0.993	0.000
L10.3 Brazilian pemphigus [fogo selvagem]	0.006	0.993	0.000
L10.2 Pemphigus foliaceus	0.006	0.993	0.000
L10.1 Pemphigus vegetans	0.006	0.993	0.000
L10.0 Pemphigus vulgaris	0.006	0.993	0.000
T50.8 Diagnostic agents	0.000	0.993	0.006
T42.8 Anti-Parkinsonism drugs and other central muscle-tone depressants	0.000	0.993	0.006
T42.5 Mixed antiepileptics, not elsewhere classified	0.000	0.993	0.006
T42.3 Barbiturates	0.000	0.993	0.006
T42.2 Succinimides and oxazolidinediones	0.000	0.993	0.006
L29.8 Other pruritus	0.006	0.993	0.000
T40.4 Other synthetic narcotics	0.000	0.993	0.006
I74 Arterial embolism and thrombosis	0.006	0.994	0.000
T37 Poisoning by other systemic anti-infectives and antiparasitics	0.000	0.994	0.006
L23.5 Allergic contact dermatitis due to other chemical products	0.006	0.994	0.000
T38 Poisoning by hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.000	0.994	0.006
L30.8 Other specified dermatitis	0.006	0.994	0.000
L27 Dermatitis due to substances taken internally	0.006	0.994	0.000
L28.2 Other prurigo	0.006	0.994	0.000
T43.4 Butyrophenone and thioxanthene neuroleptics	0.000	0.994	0.006
L29.2 Pruritus vulvae	0.006	0.994	0.000
L12.9 Pemphigoid, unspecified	0.006	0.994	0.000
L12.8 Other pemphigoid	0.006	0.994	0.000
L12.3 Acquired epidermolysis bullosa	0.006	0.994	0.000
L12.2 Chronic bullous disease of childhood	0.006	0.994	0.000
L12.0 Bullous pemphigoid	0.006	0.994	0.000
T45 Poisoning by primarily systemic and haematological agents, not elsewhere classified	0.000	0.994	0.006
I74.5 Embolism and thrombosis of iliac artery	0.006	0.994	0.000
S91.3 Open wound of other parts of foot	0.006	0.994	0.000
T47.1 Other antacids and anti-gastric-secretion drugs	0.000	0.994	0.006
L25.9 Unspecified contact dermatitis, unspecified cause	0.005	0.994	0.000
L13.9 Bullous disorder, unspecified	0.005	0.994	0.000
L13.8 Other specified bullous disorders	0.005	0.994	0.000
L13.1 Subcorneal pustular dermatitis	0.005	0.994	0.000
I46.0 Cardiac arrest with successful resuscitation	0.000	0.994	0.006
N60 Benign mammary dysplasia	0.000	0.994	0.006
T39 Poisoning by nonopioid analgesics, antipyretics and antirheumatics	0.000	0.994	0.006
I74.9 Embolism and thrombosis of unspecified artery	0.006	0.994	0.000
S06.00 Concussion (without open intracranial wound)	0.006	0.994	0.000
I74.2 Embolism and thrombosis of arteries of the upper extremities	0.006	0.994	0.000
T41.5 Therapeutic gases	0.000	0.994	0.005
T41.4 Anaesthetic, unspecified	0.000	0.994	0.005
T41.3 Local anaesthetics	0.000	0.994	0.005
T41.2 Other and unspecified general anaesthetics	0.000	0.994	0.005
T41.1 Intravenous anaesthetics	0.000	0.994	0.005
T41.0 Inhaled anaesthetics	0.000	0.994	0.005
T48.7 Other and unspecified agents primarily acting on the respiratory system	0.000	0.994	0.005
T48.6 Antiasthmatics, not elsewhere classified	0.000	0.994	0.005
T48.5 Anti-common-cold drugs	0.000	0.994	0.005
T48.4 Expectorants	0.000	0.994	0.005
T48.3 Antitussives	0.000	0.994	0.005
T48.2 Other and unspecified agents primarily acting on muscles	0.000	0.994	0.005
T48.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.000	0.994	0.005
T48.0 Oxytocic drugs	0.000	0.994	0.005
T49.9 Topical agent, unspecified	0.000	0.994	0.005
T49.8 Other topical agents	0.000	0.994	0.005
T49.7 Dental drugs, topically applied	0.000	0.994	0.005
T49.6 Otorhinolaryngological drugs and preparations	0.000	0.994	0.005
T49.5 Ophthalmological drugs and preparations	0.000	0.994	0.005
T49.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.000	0.994	0.005
T49.3 Emollients, demulcents and protectants	0.000	0.994	0.005
T49.2 Local astringents and local detergents	0.000	0.994	0.005
T49.1 Antipruritics	0.000	0.994	0.005
T49.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.000	0.994	0.005
T39.9 Nonopioid analgesic, antipyretic and antirheumatic, unspecified	0.000	0.994	0.006
L28.1 Prurigo nodularis	0.005	0.994	0.000
T36.9 Systemic antibiotic, unspecified	0.000	0.995	0.005
T36.8 Other systemic antibiotics	0.000	0.995	0.005
T36.7 Antifungal antibiotics, systemically used	0.000	0.995	0.005
T36.6 Rifamycins	0.000	0.995	0.005
T36.5 Aminoglycosides	0.000	0.995	0.005
T36.3 Macrolides	0.000	0.995	0.005
T36.2 Chloramphenicol group	0.000	0.995	0.005
T36.1 Cefalosporins and other Beta-lactam antibiotics	0.000	0.995	0.005
I74.8 Embolism and thrombosis of other arteries	0.005	0.995	0.000
T36.0 Penicillins	0.000	0.995	0.005
Z93.6 Other artificial openings of urinary tract status	0.000	0.995	0.005
T42.4 Benzodiazepines	0.000	0.995	0.005
T47.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.000	0.995	0.005
T47.8 Other agents primarily affecting the gastro-intestinal system	0.000	0.995	0.005
T47.7 Emetics	0.000	0.995	0.005
T47.5 Digestants	0.000	0.995	0.005
T47.3 Saline and osmotic laxatives	0.000	0.995	0.005
N60.3 Fibrosclerosis of breast	0.000	0.995	0.005
T36.4 Tetracyclines	0.000	0.995	0.005
T47.2 Stimulant laxatives	0.000	0.995	0.005
T47.0 Histamine H(2)-receptor antagonists	0.000	0.995	0.005
N60.4 Mammary duct ectasia	0.000	0.995	0.005
C85.9 Non-Hodgkin's lymphoma, unspecified type	0.000	0.995	0.005
T39.8 Other nonopioid analgesics and antipyretics, not elsewhere classified	0.000	0.995	0.005
L12.1 Cicatricial pemphigoid	0.005	0.995	0.000
T37.9 Systemic anti-infective and antiparasitic, unspecified	0.000	0.995	0.005
T37.5 Antiviral drugs	0.000	0.995	0.005
T37.4 Anthelminthics	0.000	0.995	0.005
T37.3 Other antiprotozoal drugs	0.000	0.995	0.005
T37.2 Antimalarials and drugs acting on other blood protozoa	0.000	0.995	0.005
T37.1 Antimycobacterial drugs	0.000	0.995	0.005
T37.0 Sulphonamides	0.000	0.995	0.005
T38.3 Insulin and oral hypoglycaemic [antidiabetic] drugs	0.000	0.995	0.005
T47.4 Other laxatives	0.000	0.995	0.005
I74.1 Embolism and thrombosis of other and unspecified parts of aorta	0.005	0.995	0.000
T38.9 Other and unspecified hormone antagonists	0.000	0.995	0.004
T38.8 Other and unspecified hormones and their synthetic substitutes	0.000	0.995	0.004
T38.7 Androgens and anabolic congeners	0.000	0.995	0.004
T38.5 Other oestrogens and progestogens	0.000	0.995	0.004
T38.4 Oral contraceptives	0.000	0.995	0.004
T38.2 Antithyroid drugs	0.000	0.995	0.004
T47.6 Antidiarrhoeal drugs	0.000	0.995	0.004
Z51.8 Other specified medical care	0.005	0.995	0.000
L27.9 Dermatitis due to unspecified substance taken internally	0.004	0.995	0.000
L27.8 Dermatitis due to other substances taken internally	0.004	0.995	0.000
N60.9 Benign mammary dysplasia, unspecified	0.000	0.995	0.005
L13.0 Dermatitis herpetiformis	0.004	0.995	0.000
T42.0 Hydantoin derivatives	0.000	0.995	0.004
T43.6 Psychostimulants with abuse potential	0.000	0.995	0.004
I74.4 Embolism and thrombosis of arteries of extremities, unspecified	0.004	0.995	0.000
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.000	0.995	0.005
N60.8 Other benign mammary dysplasias	0.000	0.995	0.005
T45.1 Antineoplastic and immunosuppressive drugs	0.000	0.995	0.004
X49.9 Unspecified place	0.004	0.995	0.000
T45.9 Primarily systemic and haematological agent, unspecified	0.000	0.996	0.004
T45.8 Other primarily systemic and haematological agents	0.000	0.996	0.004
T45.7 Anticoagulant antagonists, vitamin K and other coagulants	0.000	0.996	0.004
T45.6 Fibrinolysis-affecting drugs	0.000	0.996	0.004
T45.4 Iron and its compounds	0.000	0.996	0.004
T45.3 Enzymes, not elsewhere classified	0.000	0.996	0.004
I74.0 Embolism and thrombosis of abdominal aorta	0.004	0.996	0.000
T38.1 Thyroid hormones and substitutes	0.000	0.996	0.004
L27.2 Dermatitis due to ingested food	0.004	0.996	0.000
T39.4 Antirheumatics, not elsewhere classified	0.000	0.996	0.004
T39.2 Pyrazolone derivatives	0.000	0.996	0.004
T44 Poisoning by drugs primarily affecting the autonomic nervous system	0.000	0.996	0.004
Z93.5 Cystostomy status	0.000	0.996	0.004
H02.8 Other specified disorders of eyelid	0.000	0.996	0.004
T38.6 Antigonadotrophins. antioestrogens, antiandrogens, not elsewhere classified	0.000	0.996	0.004
T38.0 Glucocorticoids and synthetic analogues	0.000	0.996	0.004
H65.3 Chronic mucoid otitis media	0.000	0.996	0.004
T45.2 Vitamins, not elsewhere classified	0.000	0.996	0.004
T45.5 Anticoagulants	0.000	0.996	0.004
T37.8 Other specified systemic anti-infectives and antiparasitics	0.000	0.996	0.004
T45.0 Antiallergic and antiemetic drugs	0.000	0.996	0.004
T78.0 Anaphylactic shock due to adverse food reaction	0.004	0.996	0.000
S91 Open wound of ankle and foot	0.004	0.996	0.000
I73.0 Raynaud's syndrome	0.004	0.996	0.000
H02.0 Entropion and trichiasis of eyelid	0.000	0.996	0.004
L57.0 Actinic keratosis	0.004	0.996	0.000
C43.4 Malignant melanoma of scalp and neck	0.000	0.996	0.004
H44.0 Purulent endophthalmitis	0.000	0.996	0.004
Z96.0 Presence of urogenital implants	0.000	0.996	0.004
L27.1 Localised skin eruption due to drugs and medicaments	0.003	0.996	0.000
H02 Other disorders of eyelid	0.000	0.996	0.004
Y52.4 Angiotensin-converting-enzyme inhibitors	0.000	0.996	0.004
T39.0 Salicylates	0.000	0.996	0.004
H44.2 Degenerative myopia	0.000	0.996	0.004
S91.1 Open wound of toe(s) without damage to nail	0.003	0.996	0.000
T78 Adverse effects, not elsewhere classified	0.003	0.996	0.000
S91.2 Open wound of toe(s) with damage to nail	0.003	0.996	0.000
C43 Malignant melanoma of skin	0.000	0.997	0.003
T44.9 Other and unspecified drugs primarily affecting the nervous system	0.000	0.997	0.003
H44 Disorders of globe	0.000	0.997	0.003
L28.0 Lichen simplex chronicus	0.003	0.997	0.000
T23.2 Burn of second degree of wrist and hand	0.003	0.997	0.000
T44.8 Centrally acting and afrenergic-neuron-blocking agents, not elsewhere classified	0.000	0.997	0.003
T44.5 Predominantly Beta-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.4 Predominantly Alpha-adrenoreceptor agonists, not elsewhere classified	0.000	0.997	0.003
T44.2 Ganglionic blocking drugs, not elsewhere classified	0.000	0.997	0.003
T44.1 Other parasympathomimetics [cholinergics]	0.000	0.997	0.003
T44.0 Anticholinesterase agents	0.000	0.997	0.003
H02.4 Ptosis of eyelid	0.000	0.997	0.003
C43.2 Malignant melanoma of ear and external auricular canal	0.000	0.997	0.003
Y52.5 Other antihypertensive drugs, not elsewhere classified	0.000	0.997	0.003
T23 Burn and corrosion of wrist and hand	0.003	0.997	0.000
H02.1 Ectropion of eyelid	0.000	0.997	0.003
Y52.3 Coronary vasodilators, not elsewhere classified	0.000	0.997	0.003
H44.1 Other endophthalmitis	0.000	0.997	0.003
I72.0 Aneurysm of carotid artery	0.003	0.997	0.000
K56.4 Other impaction of intestine	0.000	0.997	0.003
S91.7 Multiple open wounds of ankle and foot	0.003	0.997	0.000
M48.54 Collapsed vertebra, not elsewhere classified (Thoracic region)	0.003	0.997	0.000
K55.0 Acute vascular disorders of intestine	0.003	0.997	0.000
T23.3 Burn of third degree of wrist and hand	0.003	0.997	0.000
Z93 Artificial opening status	0.000	0.997	0.003
I70.20 Atherosclerosis of arteries of extremities (without gangrene)	0.003	0.997	0.000
C43.7 Malignant melanoma of lower limb, including hip	0.000	0.997	0.003
H02.2 Lagophthalmos	0.000	0.997	0.003
Z93.0 Tracheostomy status	0.000	0.997	0.003
V23.4 Driver injured in traffic accident	0.003	0.997	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.000	0.997	0.003
T44.6 Alpha-Adrenoreceeptor antagonists, not elsewhere classified	0.000	0.997	0.003
H44.4 Hypotony of eye	0.000	0.997	0.003
X41.9 Unspecified place	0.000	0.997	0.003
H44.5 Degenerated conditions of globe	0.000	0.997	0.003
H02.7 Other degenerative disorders of eyelid and periocular area	0.000	0.997	0.003
Y52 Agents primarily affecting the cardiovascular system	0.000	0.997	0.003
S02.40 Fracture of malar and maxillary bones (closed)	0.003	0.997	0.000
H44.8 Other disorders of globe	0.000	0.997	0.003
T78.8 Other adverse effects, not elsewhere classified	0.003	0.997	0.000
T78.9 Adverse effect, unspecified	0.003	0.997	0.000
D35.0 Adrenal gland	0.003	0.997	0.000
C43.8 Overlapping malignant melanoma of skin	0.000	0.997	0.003
C43.0 Malignant melanoma of lip	0.000	0.997	0.003
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.000	0.997	0.003
Z93.9 Artificial opening status, unspecified	0.000	0.997	0.003
H44.7 Retained (old) intraocular foreign body, nonmagnetic	0.000	0.997	0.003
H44.6 Retained (old) intraocular foreign body, magnetic	0.000	0.997	0.003
H44.3 Other degenerative disorders of globe	0.000	0.997	0.003
T43.2 Other and unspecified antidepressants	0.000	0.997	0.003
C43.1 Malignant melanoma of eyelid, including canthus	0.000	0.997	0.003
C82.2 Large cell, follicular	0.000	0.997	0.003
H44.9 Disorder of globe, unspecified	0.000	0.997	0.003
T23.0 Burn of unspecified degree of wrist and hand	0.003	0.997	0.000
T21.2 Burn of second degree of trunk	0.003	0.997	0.000
T23.1 Burn of first degree of wrist and hand	0.003	0.997	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations